Phase 2b Data Presented at American Association for the Study of Liver Diseases Meeting LOUISVILLE, Colo., Nov. 2, 2009 – GlobeImmune Inc. will present Phase 2b data today at the 60th Annual Meeting of the American Association for the Study … Continue reading
GlobeImmune’s Hepatitis C Therapeutic Vaccine Combined with Standard of Care Increases End of Treatment Response Rate by 15%
November 02, 2009